KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Globus Medical (GMED) Depreciation and Depletion (2018 - 2025)

Historic Depreciation and Depletion for Globus Medical (GMED) over the last 7 years, with Q3 2025 value amounting to $41.3 million.

  • Globus Medical's Depreciation and Depletion rose 1196.27% to $41.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $157.3 million, marking a year-over-year increase of 1286.94%. This contributed to the annual value of $134.7 million for FY2024, which is 4370.13% up from last year.
  • As of Q3 2025, Globus Medical's Depreciation and Depletion stood at $41.3 million, which was up 1196.27% from $40.4 million recorded in Q2 2025.
  • Globus Medical's 5-year Depreciation and Depletion high stood at $43.0 million for Q4 2023, and its period low was $12.2 million during Q3 2021.
  • In the last 5 years, Globus Medical's Depreciation and Depletion had a median value of $14.5 million in 2021 and averaged $23.6 million.
  • Per our database at Business Quant, Globus Medical's Depreciation and Depletion crashed by 1358.75% in 2022 and then soared by 24698.48% in 2023.
  • Over the past 5 years, Globus Medical's Depreciation and Depletion (Quarter) stood at $12.3 million in 2021, then grew by 1.06% to $12.4 million in 2022, then skyrocketed by 246.98% to $43.0 million in 2023, then fell by 10.98% to $38.3 million in 2024, then grew by 7.75% to $41.3 million in 2025.
  • Its last three reported values are $41.3 million in Q3 2025, $40.4 million for Q2 2025, and $37.3 million during Q1 2025.